Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

Efficacy of influenza vaccination and tamiflu® treatment--comparative studies with Eurasian Swine influenza viruses in pigs.

Duerrwald R, Schlegel M, Bauer K, Vissiennon T, Wutzler P, Schmidtke M.

PLoS One. 2013 Apr 22;8(4):e61597. doi: 10.1371/journal.pone.0061597. Print 2013.

2.
3.

Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.

Gauger PC, Vincent AL, Loving CL, Lager KM, Janke BH, Kehrli ME Jr, Roth JA.

Vaccine. 2011 Mar 24;29(15):2712-9. doi: 10.1016/j.vaccine.2011.01.082. Epub 2011 Feb 23.

PMID:
21310191
4.

Pathogenesis and subsequent cross-protection of influenza virus infection in pigs sustained by an H1N2 strain.

Ferrari M, Borghetti P, Foni E, Robotti C, Di Lecce R, Corradi A, Petrini S, Bottarelli E.

Zoonoses Public Health. 2010 Jun;57(4):273-80. doi: 10.1111/j.1863-2378.2009.01239.x. Epub 2009 Jun 17.

PMID:
19538454
5.

Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.

Loeffen WL, Stockhofe N, Weesendorp E, van Zoelen-Bos D, Heutink R, Quak S, Goovaerts D, Heldens JG, Maas R, Moormann RJ, Koch G.

Vet Microbiol. 2011 Sep 28;152(3-4):304-14. doi: 10.1016/j.vetmic.2011.05.027. Epub 2011 May 24.

PMID:
21664078
6.

Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.

Yang H, Chen Y, Shi J, Guo J, Xin X, Zhang J, Wang D, Shu Y, Qiao C, Chen H.

Vet Microbiol. 2011 Sep 28;152(3-4):229-34. doi: 10.1016/j.vetmic.2011.04.032. Epub 2011 Apr 30.

PMID:
21596495
7.

Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.

Gauger PC, Vincent AL, Loving CL, Henningson JN, Lager KM, Janke BH, Kehrli ME Jr, Roth JA.

Vet Pathol. 2012 Nov;49(6):900-12. doi: 10.1177/0300985812439724. Epub 2012 Mar 28.

PMID:
22461226
8.

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes.

Van Reeth K, Gregory V, Hay A, Pensaert M.

Vaccine. 2003 Mar 28;21(13-14):1375-81.

PMID:
12615433
9.

The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.

Kitikoon P, Nilubol D, Erickson BJ, Janke BH, Hoover TC, Sornsen SA, Thacker EL.

Vet Immunol Immunopathol. 2006 Aug 15;112(3-4):117-28. Epub 2006 Apr 18.

PMID:
16621020
10.

Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.

Vincent AL, Lager KM, Janke BH, Gramer MR, Richt JA.

Vet Microbiol. 2008 Jan 25;126(4):310-23. Epub 2007 Jul 17.

PMID:
17719188
11.

Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.

Thomas M, Wang Z, Sreenivasan CC, Hause BM, Gourapura J Renukaradhya, Li F, Francis DH, Kaushik RS, Khatri M.

Vaccine. 2015 Jan 15;33(4):542-8. doi: 10.1016/j.vaccine.2014.11.034. Epub 2014 Nov 28.

PMID:
25437101
12.

A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.

Bragstad K, Vinner L, Hansen MS, Nielsen J, Fomsgaard A.

Vaccine. 2013 Apr 26;31(18):2281-8. doi: 10.1016/j.vaccine.2013.02.061. Epub 2013 Mar 13.

PMID:
23499598
13.
14.

Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.

Gauger PC, Loving CL, Khurana S, Lorusso A, Perez DR, Kehrli ME Jr, Roth JA, Golding H, Vincent AL.

Virology. 2014 Dec;471-473:93-104. doi: 10.1016/j.virol.2014.10.003. Epub 2014 Oct 28.

15.
16.

Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice.

Sui J, Yang D, Qiao C, Xu H, Xu B, Wu Y, Yang H, Chen Y, Chen H.

Vaccine. 2016 Jul 19;34(33):3757-63. doi: 10.1016/j.vaccine.2016.06.009. Epub 2016 Jun 16.

PMID:
27321744
17.

Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.

Richt JA, Lekcharoensuk P, Lager KM, Vincent AL, Loiacono CM, Janke BH, Wu WH, Yoon KJ, Webby RJ, Solórzano A, García-Sastre A.

J Virol. 2006 Nov;80(22):11009-18. Epub 2006 Aug 30.

18.

Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.

Gauger PC, Loving CL, Lager KM, Janke BH, Kehrli ME Jr, Roth JA, Vincent AL.

Viral Immunol. 2013 Oct;26(5):314-21. doi: 10.1089/vim.2013.0018. Epub 2013 Sep 13.

PMID:
24033080
19.

Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.

Klingbeil K, Lange E, Blohm U, Teifke JP, Mettenleiter TC, Fuchs W.

Virus Res. 2015 Mar 2;199:20-30. doi: 10.1016/j.virusres.2015.01.009. Epub 2015 Jan 17.

PMID:
25599604
20.

Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.

Wen F, Yu H, Yang FR, Huang M, Yang S, Zhou YJ, Li ZJ, Tong GZ.

Arch Virol. 2014 Nov;159(11):2957-67. doi: 10.1007/s00705-014-2151-y. Epub 2014 Jun 24.

PMID:
24957653

Supplemental Content

Support Center